BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1008@pharmaconomics
DTSTAMP:20260707T034815Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ARMP Phase 3 — AP-SA02 (estimated date)
DESCRIPTION:Phase 3 trial results for AP-SA02 in complicated bacteremia caused by Staphylococcus aureus are due ~ Dec 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/921114/000110465926060299/armp-20260512xex99d1.htm\n\nTrack it: https://www.pharmaconomics.com/e/1008
URL:https://www.pharmaconomics.com/e/1008
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ARMP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR